Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

Abroad (travel likely)RecruitingPHASE4

Conditions

Vaccine · Pneumococcal Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (LaFon, MD) · dlafon@uabmc.edu · 2059343411
Contact: Principal Investigator (David C LaFon, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers

HPV · HPV Vaccine

Abroad (travel likely)Recruiting

Lagos, Nigeria

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

Pneumococcal Disease

Abroad (travel likely)RecruitingPHASE3

Estero, United States · Fort Lauderdale, United States

How Gut Health Affects Immune Responses to the Oral Rotavirus Vaccine in Adults in Zambia

Feasibility Study · Vaccine Immune Response · Rota Virus Gastroenteritis

Abroad (travel likely)Recruiting

Lusaka, Zambia

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

Treatment · Neoantigen · Vaccine

Abroad (travel likely)Recruiting

Shanghai, China